News from ARMAGEN A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

23 Jul, 2014, 07:00 ET ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome

 ArmaGen, a privately held biotechnology company focused on developing revolutionary therapies to treat severe neurological disorders,...


04 Sep, 2013, 09:00 ET ARMAGEN® Expands Patent Portfolio With Issuance Of Two Additional U.S. Patents

ARMAGEN, a leader in the field of transporting therapeutics across the blood brain barrier (BBB) today announced the issuance of two additional...


18 Jul, 2013, 13:22 ET ARMAGEN® Receives US Orphan Designation For Lead Product AGT-182

 ARMAGEN announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its lead product AGT-182 for...